Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.2%

166 terminated/withdrawn out of 1363 trials

Success Rate

84.4%

-2.1% vs industry average

Late-Stage Pipeline

10%

130 trials in Phase 3/4

Results Transparency

40%

363 of 901 completed trials have results

Key Signals

160 recruiting363 with results117 terminated49 withdrawn

Enrollment Performance

Analytics

N/A
604(57.3%)
Phase 2
172(16.3%)
Phase 1
120(11.4%)
Phase 4
98(9.3%)
Phase 3
32(3.0%)
Early Phase 1
29(2.7%)
1055Total
N/A(604)
Phase 2(172)
Phase 1(120)
Phase 4(98)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1363)

Showing 20 of 1363 trials
NCT07475130Not ApplicableCompleted

Defy The Odds: Exercise Forecasting and Motivation Strategies for Prolonged-Sitting Jobs

Role: lead

NCT04706026Not ApplicableActive Not Recruiting

A Pilot Study of Local Anesthesia for Inguinal Hernia Surgery in Older Adults

Role: lead

NCT06763952Not ApplicableNot Yet Recruiting

Leveraging Artificial Intelligence to Prevent Vision Loss From Diabetes

Role: lead

NCT06472726Not ApplicableTerminated

Mental Health App for Cancer Survivors Study

Role: lead

NCT02190253Completed

Seroprevalence of Hepatitis E in People With an Organ Transplant

Role: collaborator

NCT04806347Phase 1Recruiting

Alpha/Beta T-cell Depleted Blood-forming Stem Cell Transplant From Related or Unrelated Donors for Blood Diseases in Children and Young Adults

Role: lead

NCT06292637Not ApplicableActive Not Recruiting

Cognitive Behavioral and Faith Fellowship to Improve Thy Health

Role: lead

NCT07756606Not ApplicableNot Yet Recruiting

Evaluating the Impacts of Informal Tick and Tickborne Disease Educational Tools on Children

Role: lead

NCT07680114Not ApplicableRecruiting

Overnight Thalamic TES-TI to Modulate Sleep Spindles in Individuals With Schizophrenia Spectrum Disorders and Matched Healthy Controls

Role: lead

NCT07767968Not ApplicableNot Yet Recruiting

LapBox® Manual Containment System

Role: lead

NCT07609225Early Phase 1Not Yet Recruiting

Chemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceutical Therapy

Role: lead

NCT07674784Not ApplicableRecruiting

Interventions to Enhance Quadriceps Output After ACLR

Role: lead

NCT07219719Phase 1Recruiting

Temporal Interference for Thalamocortical Activity and Network Modulation

Role: lead

NCT05816785Early Phase 1Completed

Pilot Study of Imatinib Cetuximab Combo for H & N Cancer

Role: lead

NCT05647564Not ApplicableRecruiting

PET/CT Characterization of Treatment Resistance

Role: lead

NCT07440004Phase 1Completed

Testing a Digital Mindfulness Program to Support People Experiencing Suicidal Thoughts

Role: lead

NCT06940427Phase 2Recruiting

Development of FAPI PET as a Non-invasive Biomarker of Pulmonary Fibrogenesis

Role: lead

NCT06966375Not ApplicableRecruiting

Worldwide Yearly Screening for Hypospadias

Role: lead

NCT05521698Phase 1Recruiting

A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer

Role: lead

NCT04989946Phase 1Active Not Recruiting

Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer

Role: lead